LGND - Ligand Pharmaceuticals orporated - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

LGND is currently covered by 6 analysts with an average price target of $91.01. This is a potential upside of $19.74 (27.7%) from yesterday's end of day stock price of $71.27.

Ligand Pharmaceuticals orporated's activity chart (see below) currently has 111 price targets and 86 ratings on display. The stock rating distribution of LGND is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 72.04% with an average time for these price targets to be met of 254.5 days.

Highest price target for LGND is $144, Lowest price target is $95, average price target is $91.01.

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 29-Feb-2024. First documented stock forecast 12-Feb-2014.

Currently out of the existing stock ratings of LGND, 17 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

144

$72.73 (102.05%)

144

1 months ago

21/32 (65.63%)

$64.65 (81.47%)

372

Buy

95

$23.73 (33.30%)

95

3 months 16 days ago

1/4 (25%)

$27.72 (41.20%)

261

Buy

110

$38.73 (54.34%)

120

8 months 4 days ago

5/12 (41.67%)

$42.7 (63.45%)

238

Buy

95

$23.73 (33.30%)

90

1 years 27 days ago

12/18 (66.67%)

$19.99 (26.65%)

224

Buy

81.1

$4.82 (6.32%)

124.77

1 years 10 months 12 days ago

1/2 (50%)

$25.13 (44.90%)

178

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LGND (Ligand Pharmaceuticals orporated) average time for price targets to be met?

On average it took 254.5 days on average for the stock forecasts to be realized with a an average price target met ratio 72.04

Which analyst has the current highest performing score on LGND (Ligand Pharmaceuticals orporated) with a proven track record?

SCOTT HENRY

Which analyst has the most public recommendations on LGND (Ligand Pharmaceuticals orporated)?

Scott Henry has 2 price targets and 1 ratings on LGND

Which analyst is the currently most bullish on LGND (Ligand Pharmaceuticals orporated)?

Joseph Pantginis with highest potential upside - $72.73

Which analyst is the currently most reserved on LGND (Ligand Pharmaceuticals orporated)?

Esther Rajavelu with lowest potential downside - -$5.77

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?